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Background: Prognosis research studies (e.g. those deriving prognostic models or examining potential predictors
of outcome) often collect information on time-varying predictors after their intended moment of use, sometimes
using a measurement method different to that which would be used. We aimed to illustrate how estimates of
predictor-outcome associations and prognostic model performance obtained from such studies may differ to those
at the earlier, intended moment of use.
Methods: We analysed data from two primary care cohorts of patients consulting for non-inflammatory
musculoskeletal conditions: the Prognostic Research Study (PROG-RES: n = 296, aged >50 years) and the Primary
care Osteoarthritis Screening Trial (POST: n = 756, >45 years). Both cohorts had collected comparable information on
a potentially important time-varying predictor (current pain intensity: 0–10 numerical rating scale), other predictors
(age, gender, practice) and outcome (patient-perceived non-recovery at 6 months). Using logistic regression
models, we compared the direction and magnitude of predictor-outcome associations and model performance
measures under two scenarios: (i) current pain intensity ascertained by the treating general practitioner in the
consultation (the intended moment of use) and (ii) current pain intensity ascertained by a questionnaire mailed
several days after the consultation.
Results: In both cohorts, the predictor-outcome association was substantially weaker for pain measured at the
consultation (OR (95% CI): PROG-RES 1.06 (0.95, 1.18); POST 1.04 (0.96, 1.12)) than for pain measured in the
questionnaire (PROG-RES 1.34 (1.20, 1.48); POST 1.26 (1.18, 1.34)). The c-statistic of the multivariable model was
lower when pain was measured at the consultation (c-statistic (95% CI): PROG-RES 0.57 (0.51, 0.64); POST 0.66 (0.
62, 0.70)) than when pain was measured in the questionnaire (PROG-RES 0.69 (0.63, 0.75); POST 0.72 (0.68, 0.76)),
reflecting the lower OR for pain at the consultation.
Conclusions: Prognostic research studies ideally should measure time-varying predictors at their intended
moment of use and using the intended measurement method. Otherwise, they may produce substantially
different estimates of predictor-outcome associations and model performance. Researchers should report when,
how and where predictors were measured and identify any significant departures from their intended use that
may limit the applicability of findings in practice.
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Trial registration: The protocol for the PROG-RES cohort data collection and primary analysis has been published in an
open-access journal (Mallen et al., BMC Musculoskelet Disord 7:84, 2006). The POST trial was registered (ISRCTN40721988;
date of registration: 21 June 2011; date of enrolment of the first participant: 3 October 2011) and had a pre-specified
protocol covering primary analysis. There was no published protocol for the current secondary analyses presented in
this manuscript.
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Time-varying predictors, BiasBackground
Prognosis research studies are used to help summarise
and predict future outcomes in patients with a particular
disease or health condition [1]. In particular, many stud-
ies which examine potential predictors (prognostic fac-
tors) of outcome risk [2] and/or develop a prognostic
model containing multiple predictors for individualised
risk prediction [3] are published each year. Prognostic
models are intended “to assist clinicians with their
prediction of a patient’s future outcome and to enhance
informed decision making with the patient” [4]. Predic-
tions from these models should have optimal performance
at the time that they are practically implemented—the
“intended moment of using the model” [5]. The TRIPOD
(Transparent Reporting of a multivariable prediction
model for Individual Prognosis or Diagnosis) statement
recommends to clearly define when the predictors used in
the development of the model were measured [6] and
states that “all predictors should be measured before or at
the study time origin and known at the intended moment
the model is intended to be used” [7]. In the context of
primary care, this will typically be at the point of care—the
primary care consultation. For a range of practical and
ethical reasons, researchers may design prognosis research
studies that collect predictor information after the
intended moment of use. For example, one approach
commonly used in prognosis studies of recurrent and
long-term conditions presenting to primary care is for in-
formation on predictors (such as pain intensity) to be
ascertained by mailed self-complete questionnaires, or
personal interview and examination in research clinics
several days after their index consultation (e.g. [8–14]).
This approach offers several advantages, as it facilitates: 1)
a wider range of predictor information to be collected
than would be possible within the time-constrained pri-
mary care consultation, 2) greater standardisation of data
collection procedures, 3) a “cooling off period” between
being informed about the study at the point of care, and
consenting to provide information on potential predictors
that would not be considered part of routine care. How-
ever, this practice also carries potential limitations when
the measured values of the predictors included in these
studies are time-dependent and particularly when theymay additionally be sensitive to the choice of measure-
ment, mode of administration and other contextual influ-
ences on participants’ responses [15–17]. In these
circumstances, estimates of predictor-outcome associa-
tions and prognostic model performance obtained from
the study may be systematically different (biased) from
those that would have been observed had those predic-
tors been measured at the point of care. This problem
is what is referred to as indirectness in the GRADE
guidelines [18], the effect of which could be assessed in
a particular prognostic model if external validation was
performed in a setting and timeframe the same as when
the model would be used in practice, as recommended
in the REMARK guidelines [19].
The aim of this study was to illustrate this concern
using a real example, showing how using a measure
recorded shortly after a patient’s index consultation to
develop a prediction model can provide misleading pre-
diction estimates if used during this index consultation.
Developing a prediction model intended to be imple-
mented in practice is not the purpose of this study. We
compare the direction and magnitude of predictor-
outcome associations and also the differences in the
Akaike’s information criterion (AIC) and c-statistic of a
multivariable prognostic model, under two scenarios:
firstly, using a time-varying predictor of interest, ascer-
tained by the treating physician at the point of care (i.e.
at the intended moment of use), and secondly, using the
same predictor, but ascertained by a self-complete ques-
tionnaire mailed several days after the point of care. Our
predictor of interest is current pain intensity in patients
presenting to primary care with non-inflammatory mus-
culoskeletal disorders, which has previously been found
to be a predictor of unfavourable episode outcomes in
several previous primary care studies [20].
Methods
We undertook secondary analyses of two primary care lon-
gitudinal datasets: the Prognosis Research Study (PROG-
RES), an observational study [21], and the Primary care
Osteoarthritis Screening Trial (POST) (ISRCTN40721988),
a cluster randomised trial. PROG-RES focussed on consult-
ation for non-inflammatory musculoskeletal pain and
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included a brief, standardised assessment of predictors dur-
ing the consultation (point of care) by the treating general
practitioner (GP) which they recorded on the practice
computer. The studies had similar patient populations, re-
cruitment procedures, and measurement of predictors
and outcome, thereby allowing us to observe whether
similar findings were present within the two compar-
able studies (Table 1).
The outcome of interest in the current study was the
self-reported patient global rating of change recorded in
the 6-month post-consultation questionnaire. The cat-
egorical responses were dichotomised into having expe-
rienced a favourable outcome (completely recovered,Table 1 Design and sample characteristics of the two questionnaire
PROG-RES
Design Prospective observational cohort
Registration (Protocol [21])
Intervention Usual care
Setting 5 general practices in North Staffords
England
Period of recruitment Sep 2006–Apr 2007
Inclusion criteria Consecutive patients aged 50+ years
for non-inflammatory musculoskeleta
Exclusion criteria Vulnerable patient (e.g. diagnosed w
recent trauma associated with signifi
inflammatory arthropathy
Data collection pointsa In GP consultation (point of care), pos
questionnaire, 3 months, 6 months, 12
24 months, 36 months
Candidate predictor of interest Current pain intensity (0–10 NRS [23]
Timing of predictor measurement 1. Point of care
2. Post-consultation questionnaire
Outcome of interest Patient global rating of change at 6
vs same/worse/much worse [22])
Participants eligible for inclusion in
main analyses
296
Age (years): mean (SD) 64.8 (9.8)
Male: no. (%) 120 (40.5)
Current pain intensity at point of
care (0–10): mean (SD)
5.9 (2.2)
Current pain intensity in
questionnaire (0–10): mean (SD)
5.5 (2.6)
Interval between point of care and
return of questionnaire (days): median
(IQR; range)
17 (13, 27; 6–75)
Unfavourable outcome at 6 months:
no. (%)
144 (48.7)
Abbreviations: C control, GP general practitioner, I intervention, IQR inter-quartile ran
Osteoarthritis Screening Trial, PROG-RES Prognostic Research Study, RCT randomise
aData collection points indicated in italics are the collection points used for this anamuch improved or improved) or an unfavourable out-
come (same, worse or much worse) [22].
Our key interest was the predictor-outcome associ-
ation between an unfavourable outcome at 6 months
and current pain intensity (0–10 numerical rating scale
(NRS); 0 = no pain [23]). Pain intensity is a time-varying
predictor, and we compared its association with an un-
favourable outcome on two occasions: (i) at the point of
care as recorded by the GP and (ii) recorded in a ques-
tionnaire by the patient sent within the week following
point of care. Although the questionnaire was mailed
within the week after the patient’s first visit to their GP,
in both studies over a quarter of the questionnaires were
returned at least a month after their consultation.s
POST
Cluster RCT
Current Controlled Trials ISRCTN40721988
I: ultra-brief screening questions for anxiety and
depression + pain intensity measurement
C: screen for pain intensity
hire, 45 general practices in West Midlands, England
Sep 2011–Nov 2012
consulting
l pain
Consecutive patients aged 45+ years consulting for
suspected or diagnosed peripheral joint osteoarthritis
ith dementia);
cant injury;
Vulnerable patient (e.g. diagnosed with a terminal illness);
nursing home resident; recent trauma associated with
significant injury; inflammatory arthropathy, crystal
disease, SpA, PMR
t-consultation
months,
In GP consultation (point of care), post-consultation
questionnaire, 3 months, 6 months, 12 months
)
months (completely recovered/much improved/improved
756
65.8 (9.9)
339 (44.8)
6.2 (2.1)
5.3 (2.6)
21 (16, 30; 3–81)
412 (54.5)
ge, NRS numerical rating scale, PMR polymyalgia rheumatica, POST Primary care
d controlled trial, SD standard deviation, SpA spondyloarthritis
lysis
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questionnaires and the instructions to GPs measured
current pain intensity in the same standardised format
with the same anchors: “How would you rate your pain
on a 0–10 scale at the present time, that is right now,
where 0 is ‘no pain’ and 10 is ‘pain as bad as could be’?”
Participants were eligible for inclusion in the current
analyses if they had returned their questionnaire,
consented to the use of medical records (such that their
point of care information was available), and were
successfully followed up at 6 months.
Statistical analysis: predictor-outcome associations
Logistic regression models were fitted to estimate the
adjusted predictor-outcome association between an
unfavourable outcome at 6 months and pain intensity
rating when recorded (i) at the point of care (i.e.
intended point of using the prognostic results) and then
(ii) in the questionnaire. Pain intensity was always in-
cluded as a continuous variable, and its association with
outcome was always included as a linear term. Adjust-
ment factors within all of the models were age (as a lin-
ear term), gender and general practice. Only patients
with complete predictor information at the point of care
and the questionnaire, with outcome information avail-
able at 6 months, were included to ensure all analyses
were comparable. Within the POST dataset, the models
also included treatment arm as an additional adjustment
factor, to account for any differences between the treat-
ment and control groups within the study. The adjusted
predictor-outcome association estimates (odds ratios
(OR)) and 95% confidence intervals (CI) from the point
of care model were compared with those from the ques-
tionnaire model, for each of PROG-RES and POST data-
sets separately. Although general practice was modelled
as fixed effects, the same pattern of findings was ob-
served when fitting general practices as random effects.
Statistical analysis: prognostic model performance
Next, each of the logistic regression models fitted was
considered as a prognostic model, such that they were to
be (hypothetically) used for predicting individual out-
come risk in new individuals. This allowed us to focus
on their overall predictive performance and in particular
to compare the performance of the models fitted at the
point of care with the models fitted using the question-
naire information. The performance measures examined
were the Akaike’s information criterion (AIC) and
discrimination.
The AIC measures the relative goodness of fit of a
model, considering both the statistical goodness of fit
and the number of parameters used. The formula for the
AIC is AIC = 2K − 2 ln(likelihood), where K is the num-
ber of parameters in the model and ln is the naturallogarithm. The model with the lowest AIC is the pre-
ferred model, but as a rule of thumb, two models are
essentially equivalent if the difference in their AICs is
less than 3 units (when the sample size is greater
than 256) [24].
We measured discrimination by the concordance
index (c-statistic) [25], which is the ability of a model to
differentiate between those who do or do not experience
the outcome of interest; in this case, it is the ability of
the model to differentiate between those who do or do
not experience an unfavourable outcome at 6 months.
The c-statistic is the probability that for any randomly
selected pair of individuals, one with an unfavourable
outcome and one without, the model assigns a higher
probability to the individual with the unfavourable
outcome. For logistic regression models, as used in this
study, the c-statistic is identical to the area under the
receiver operating characteristic curve (AUC). A c-statis-
tic of 0.5 indicates that the model is no better than
chance, and a value of 1 indicates that the model per-
fectly classifies the individuals.
Statistical analysis: sensitivity analyses
Sensitivity analyses were performed to evaluate assump-
tions made during the main analyses.
The presence of an interaction between pain intensity
rating and treatment arm was tested in the point of care
and questionnaire models by including an interaction
term of pain intensity rating with treatment arm (POST
data only), as responders who received treatment may
have a different relationship between their pain ratings
and outcome than those who did not receive treatment.
Our main analyses only included patients with
complete data for point of care, questionnaire and out-
come. To evaluate the impact of including other patients
with some missing data, the main analyses were re-
peated, first by including those extra patients in the
point of care model who had missing information at the
questionnaire and then by including the extra patients in
the questionnaire model who had missing information at
the point of care.
All analyses were performed using Stata/MP 14.0
(Stata Corporation, TX, USA).
Results
Data description
Of 650 potentially eligible patients mailed a questionnaire
in PROG-RES, 424 (65.2%) returned it, consented to med-
ical record review and had information at their consult-
ation recorded, of whom 296 (45.5%) were also successfully
followed up at 6 months. The corresponding figures for
POST were 2042, 1230 (60.2%) and 756 (37.0%) (flow-
charts provided in Fig. 1). Data was complete for age,
gender, general practice and (in POST) treatment arm.
Fig. 1 Participant flow. a PROG-RES. b POST
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did not differ by age or gender but had slightly higher
mean pain ratings at the point of care and in the
questionnaire in PROG-RES (point of care: mean
(SD): responders 5.9 (2.2) vs non-responders 6.4 (2.2);
questionnaire: 5.5 (2.6) vs 5.6 (2.5)) and in POST (6.2
(2.1) vs 6.6 (2.0); 5.3 (2.6) vs 5.8 (2.6)).
Table 1 shows the characteristics of those with complete
data included in the main analyses. The proportion report-
ing an unfavourable outcome at 6 months was 48.7% inPROG-RES and 54.5% in POST. In both studies, a signifi-
cant fall in pain intensity ratings between point of care and
the questionnaire measurement was observed, tested using
a paired t test (PROG-RES: mean (SD) 5.9 (2.2) vs 5.5 (2.6),
mean difference (SD) 0.42 (0.17), P = 0.006; POST: 6.2 (2.1)
vs 5.3 (2.6), 0.89 (0.09), P < 0.001).
Preliminary analyses
In PROG-RES, a significant mean reduction in pain
score overall between point of care and questionnaire
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favourable outcome at 6 months (mean reduction
(SD) 1.12 (0.24), P < 0.001) but not in those with an
unfavourable outcome (−0.32 (0.21), P = 0.932). Simi-
lar mean reductions were seen in POST (favourable
outcome 1.59 (0.15), P < 0.001; unfavourable outcome
0.31 (0.12), P = 0.004).
Examination of predictor-outcome associations
At the point of care, there was only a weak and non-
statistically significant independent association found be-
tween pain intensity and an unfavourable outcome in
both PROG-RES (adjusted OR (95% CI) 1.06 (0.95,
1.18)) and POST (1.04 (0.96, 1.12)) (Table 2). To trans-
late this to absolute risk, we transformed the fitted
models back to the probability scale. Figure 2 shows that
(for a female patient from a randomly selected practice
with the mean age in the dataset) there was little change
in the predicted probability of an unfavourable outcome
as pain intensity at point of care increased, in both
POST and PROG-RES.
In contrast, the models estimating the independent
association between the questionnaire pain rating and
outcome found a stronger and statistically significant re-
lationship. In PROG-RES, for each unit increase in pain
rating, the odds of an unfavourable outcome increased
by 34% (adjusted OR (95% CI) 1.34 (1.20, 1.48)), and in
POST, for each unit increase in pain rating, the odds of
an unfavourable outcome increased by 26% (1.26 (1.18,
1.34)) (Table 2). Transforming the models back to the
absolute risk scale, Fig. 2 shows that (for a female patient
from a randomly selected practice with the mean age in
the dataset) the predicted probability of an unfavourable
outcome increased at similar rates as pain intensity at
the questionnaire increased, in both datasets. The
change in predicted probability is far steeper for the
questionnaire models than for the point of care models.
For example, in POST, the predicted probability for an
individual with a pain score of 8 was 0.59 when using
the questionnaire model but 0.44 when using the point
of care model.
Examination of prognostic model performance
Table 3 shows the performance measures for the fitted
models from Table 2. The AIC for the questionnaireTable 2 Predictor-outcome association between a one-unit increase
Intended moment of using
the prognostic results
Current pain intensity (0–10 NRS) measured at:
Point of care Yes
Post-consultation questionnaire No
aAdjusted for age, gender, general practice (and treatment allocation—POST only)models was lower than that for the point of care models
in both datasets, with a difference of 32 units in PROG-
RES and 50 units in POST, suggesting that the models
fitted using the pain score measured in the questionnaire
had a better overall fit than the models using the pain
score recorded at the point of care. The c-statistics were
higher for the questionnaire models than for the point
of care models in both datasets, and thus, the discrimin-
ation was larger when pain intensity was measured in
the questionnaire. This concurs with the larger odds ra-
tio estimates for pain intensity from the questionnaire
than those from the point of care.
Sensitivity analyses
We found no strong evidence of an interaction between
treatment arm and pain intensity ratings at the point of
care (OR (95%CI) 0.92 (0.78, 1.08)) or between treat-
ment arm and questionnaire pain ratings (0.92 (0.81,
1.06)) in the POST dataset.
In the sensitivity analyses deriving models including
the patients missing pain ratings either at the point of
care or at questionnaire, the strength of associations be-
tween pain intensity and outcome did not change from
those found in the main analyses: PROG-RES point of
care: OR (95% CI) 1.06 (0.96, 1.18), n = 303; question-
naire: 1.34 (1.20, 1.48), n = 317 and POST 1.04 (0.96,
1.12), n = 757; 1.24 (1.17, 1.31), n = 904.
Discussion
Our study illustrates how the magnitude of predictor-
outcome associations and prognostic model perform-
ance can depend on when and/or how time-varying
predictors are measured. In our example with patients
presenting with musculoskeletal pain to general practice,
associations between outcome risk and pain intensity re-
corded at the intended moment of use were lower in
magnitude than those associations derived from a self-
complete questionnaire mailed to patients up to 1 week
later. Our findings were replicated in two datasets.
Despite many published studies of musculoskeletal pain
in primary care [20], very few report the collection of
time-varying predictor information by the GP at the
initial point of care [26]. When a later time is used, and/
or with a different measurement method, the study’s
predictor-outcome associations and prognostic modelin pain intensity and an unfavourable outcome
PROG-RES (n = 296) POST (n = 756)
Adjusted ORa (95% CI) Adjusted ORa (95% CI)
1.06 (0.95, 1.18) 1.04 (0.96, 1.12)
1.34 (1.20, 1.48) 1.26 (1.18, 1.34)
0
.1
.2
.3
.4
.5
.6
.7
.8
.9
1
0 2 4 6 8 10
Pain intensity (0−10 NRS)
P
re
di
ct
ed
 p
ro
ba
bi
lit
y
0
.1
.2
.3
.4
.5
.6
.7
.8
.9
1
0 2 4 6 8 10
Pain intensity (0−10 NRS)
P
re
di
ct
ed
 p
ro
ba
bi
lit
y
0
.1
.2
.3
.4
.5
.6
.7
.8
.9
1
0 2 4 6 8 10
Pain intensity (0−10 NRS)
P
re
di
ct
ed
 p
ro
ba
bi
lit
y
0
.1
.2
.3
.4
.5
.6
.7
.8
.9
1
0 2 4 6 8 10
Pain intensity (0−10 NRS)
P
re
di
ct
ed
 p
ro
ba
bi
lit
y
Point of Care Questionnaire
P
R
O
G
−
R
E
S
P
O
S
T
Fig. 2 Predicted probability (95% confidence interval) of an unfavourable outcome at 6 months by pain intensity rating estimated from the point
of care and questionnaire models (for a female patient from a randomly selected practice with the mean age in the dataset)
Whittle et al. Diagnostic and Prognostic Research  (2017) 1:1 Page 7 of 9performance may be misleading, and thus, it could signal
that the study is at high risk of bias and not applicable
for its intended purpose.
Several phenomena may contribute to the observed dis-
crepancy in predictor-outcome associations at the point of
care and at a later time point. Firstly, the timing of pre-
dictor measurement may be critical. For example, most
musculoskeletal disorders follow an episodic course and
therefore, as would be expected, patients in POST and
PROG-RES were likely to consult when their pain was
more severe than usual. This creates the conditions for re-
gression to the mean following the point of care [27, 28].
An initial reduction in group-average pain intensity rating
within the first few days following primary care consult-
ation has been consistently observed for acute, recurrent
and chronic low back pain [29–32]. A similar pattern is
likely across other non-inflammatory regional musculo-
skeletal pains. Although regression to the mean was
evident within this study, the whole group mean was
lower at the post-consultation questionnaire than at theTable 3 Measures of model performance at the point of care and q
Intended moment of using
the prognostic results
Current pain intensity (0–10 NRS) measured at:
Point of care Yes
Post-consultation questionnaire Nopoint of care and so regression to the mean does not,
therefore, provide a full explanation for the findings.
The differences found in the strengths of the predictor-
outcome associations could also relate to differences in
measurement methods. At the point of care, pain intensity
measurement was verbally administered and recorded by
the physician in a face-to-face consultation. Although in
both studies physicians were given guidance on how to
gather this information, we cannot know the extent to
which physicians recorded their judgements of patients’
pain. Physician ratings tend to systematically underesti-
mate patients’ own ratings of pain [33, 34]. Assuming that
patients’ pain ratings were elicited and faithfully recorded
at the point of care, it is nevertheless possible that a form
of end-aversion bias [15] may operate in the clinical en-
counter, i.e. patients avoid reporting pain at either end of
the severity scale in fear of being judged undeserving or
exaggerating (although evidence from this study suggests
this may be true of the lower end of the scale but not of
the upper end of the scale).uestionnaire in PROG-RES and POST
PROG-RES POST
AIC c-statistic AIC c-statistic
421.8 0.57
(0.51, 0.64)
1066.2 0.66
(0.62, 0.70)
389.8 0.69
(0.63, 0.75)
1015.8 0.72
(0.68, 0.76)
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if the setting and method of measurement were consis-
tent—the predictor-outcome associations may not agree
simply by chance variation. Further, if the measurement
error was largest at the point of care, then the observed
predictor-outcome association may be more biased at
the point of care, than observed when measured at a
later time point. If measurement error is present, it is
likely that in this situation it would be differential meas-
urement error, and the impact of differential measure-
ment could either exaggerate or underestimate the
effect. Indeed, the predictor-outcome associations esti-
mated in this study at the point of care and at question-
naire are both likely to be biased as we did not adjust
for measurement error due to insufficient information.
Nevertheless, this is unlikely to account for the entire
difference in magnitude of the estimated associations at
point of care and questionnaire. Dependent error is also
likely within this example, as a reduction in pain after
the consultation (measured in the post-consultation
questionnaire) is intrinsically going to be part of the
patient’s judgement at 6 months about whether or not
they have improved, particularly because these were
measured by the same method, and this bias will likely
be greater the closer in time the post-consultation ques-
tionnaire measurement is to the measurement of the
outcome. This is a limitation of this particular example,
and the bias created by this limitation may be less likely
to be encountered in other prognostic models.
We focussed on predictor-outcome associations intended
to be used at the point of care but derived using data
collected after the point of care. It may be that a review ap-
pointment 2–3 weeks after the first consultation may be a
better “intended moment of use” for prognostic models in
this field. Either way, it is clear from our example that the
developed prognostic model needs to use data for time-
varying predictors measured at the time of its intended use,
as otherwise discrepant associations may be included. It
may be considered that the model using the score at the
later time point should be used as this is performing better,
but this model would be misleading if used during the con-
sultation. For example, if we look at the example prediction
plots in Fig. 2, if a patient visited their GP and reported a
pain intensity score of 8, using the model developed with
the score from the questionnaire would give this patient a
predicted probability of experiencing an unfavourable out-
come of 0.65. If the model developed using the point of
care score was used, their predicted probability would be
approximately 0.5.
While we believe that the problem we highlight may
extend to other commonly investigated predictors whose
values are sensitive to the timing and mode of collection,
we have only demonstrated this problem for one pre-
dictor and thus this remains to be evaluated morewidely. Further research should assess whether similar
findings are found with other time-varying predictors
and indeed in other clinical conditions and settings.
A future study in which the same mode of data collec-
tion is used at the point of care and at post-consultation
questionnaire (e.g. patient self-administered question-
naire) is needed to better understand the relative contri-
bution of timing and mode of collection and therefore
determine whether and how improved prediction is
achievable at the point of care.Conclusions
Our findings imply the need for caution when applying
predictor-outcome associations or prognostic models
derived from prognosis research studies that record
time-varying predictors at a different time and/or by a
different measurement method than is intended upon
clinical application. This argument reinforces the need
for clearly reporting the intended moment of use in
prognostic research and when the predictors were mea-
sured [6]. Displacing the collection of time-varying pre-
dictor information from the intended moment (and
mode) of use can result in differences in the magnitude
of predictor-outcome associations and the subsequent
accuracy of prognostic model performance. In particu-
lar, predictors and models that appear to discriminate
well in research studies may fail to live up to those ex-
pectations when applied or externally validated at the
intended moment of use. This concern is likely to be
particularly justified when the outcome in some way
incorporates the prognostic factor, when the interval
between later measurement and outcome is short, and
when the same mode of assessment is used to collect
predictor and outcome information [35]. Unless shown
otherwise in validation studies using predictors mea-
sured at the correct time, previously developed predic-
tion models that include time-varying predictors
measured after the intended moment of use may over-
estimate individual risk of experiencing the outcome of
interest, which also reinforces the need for external
validation and reporting of differences between valid-
ation and development data [5].Abbreviations
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